5 月 8 泌尿外科和泌尿妇科 Three-Year Data from ROBUST III Confirms Long-Term Durability of Optilume® Drug-Coated Balloon for Recurrent Urethral Strictures Laborie Medical Technologies Corp. (Laborie), a global leader in diagnostic and … 阅读更多
1 月 17 泌尿外科和泌尿妇科 Optilume Drug-Coated Balloon Shows Long-Term Efficacy for Urethral Strictures: Five-Year Data Published in the Journal of Urology 阅读更多
10 月 28 未分类 | 泌尿外科和泌尿妇科 Optilume® BPH Catheter System Issued Category 1 CPT Code by American Medical Association 阅读更多
5 月 13 泌尿外科和泌尿妇科 Laborie Unveils Positive Study Results for Optilume® BPH Catheter System Laborie announced positive 2-year and 5-year results from studies for its Optilu … 阅读更多
4 月 30 泌尿外科和泌尿妇科 NHS England Reimburses Optilume® Urethral Drug Coated Balloon as Part of the Specialised Services Device Programme Laborie welcomed the inclusion of Optilume® Urethral Drug-Coated Balloon (DCB) i … 阅读更多
3 月 29 泌尿外科和泌尿妇科 Laborie Medical Technologies Invests in iO Urology and the CarePath Uroflow Device Laborie Medical Technologies announced a strategic equity investment in Bright … 阅读更多
10 月 27 未分类 | 泌尿外科和泌尿妇科 Laborie Medical Technologies Acquires Urotronic Urotronic joins Laborie as part of a long-term growth strategy for the Portsmout … 阅读更多
9 月 6 未分类 | 泌尿外科和泌尿妇科 Laborie Medical Technologies Announces Agreement to Acquire Urotronic for up to $600 Million Acquisition expands urology portfolio and demonstrates Laborie’s commitment to p … 阅读更多
4 月 12 泌尿外科和泌尿妇科 Urethral Stricture Treatment If you or a loved one frequently has trouble urinating, […] 阅读更多
